EUVIMEDEUVIMED entdecken
LeitlinieÜbersichtsarbeitOpen Access · CC BY 4.0

Evidence-based clinical practice guidelines for peptic ulcer disease 2026

Mitsushige Sugimoto, Tomoari Kamada, Masanori Ito, Junichi Iwamoto, Tadayoshi Okimoto, Shoko Ono, Takeshi Kanno, Toshimi Chiba, Kengo Tokunaga, Sachiyo Nomura, Takahisa Murao, Toshio Watanabe und 32 weitere

Journal of Gastroenterology · 2026

DOI: 10.1007/s00535-026-02504-3 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Gastroenterology, 2026. Verfasst von Mitsushige Sugimoto und 43 weiteren Autor:innen. Beteiligte Einrichtung: Guidelines Committee for Creating and Evaluating the ''Evidence-Based Clinical Practice Guidelines for Peptic Ulcer 2026 (4th Edition)," the Japanese…. Hauptthemen laut MEDLINE: Helicobacter Infections, Peptic Ulcer. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2026, the fourth edition of the evidence-based clinical practice guidelines for peptic ulcer disease by the Japanese Society of Gastroenterology (JSGE) was revised. These revised guidelines cover epidemiology, hemorrhagic peptic ulcers, Helicobacter pylori eradication therapy, non-eradication therapy, drug-induced ulcers, non -H. pylori , and nonsteroidal anti-inflammatory drug (NSAID) ulcers, remnant gastric ulcers, surgical treatment, and conservative therapy for perforation and stenosis. Although H. pylori infection and NSAIDs use remain two major causes of peptic ulcers, the prevalence and mortality rates of peptic ulcer have been declining due to the widespread use of eradication therapy and development of potent acid-inhibitory drugs in recent years. However, an increasing trend in idiopathic ulcers and ulcers caused by non- H. pylori Helicobacter (NHPH) infection has attracted attention. In this revised edition, therapeutic algorithms for the treatment of peptic ulcers based on H. pylori infection, low-dose aspirin (LDA) or NSAID use, ulcer history, and ulcer complications (e.g., hemorrhage) remain largely unchanged. This edition shows options for H. pylori eradication in various situations compared with the previous edition, and recommends the most effective regimens, regardless of Japanese insurance coverage. In addition, a new flowchart outlining the eradication treatment process has been presented. Compared with the previous version, the main changes in pharmacological treatment have been made: due to its acid-inhibitory characteristics compared with proton pump inhibitors and increased evidence of its efficacy and safety, vonoprazan has now been selected as the first-line treatment for peptic ulcers and NSAID- and LDA-induced ulcers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsPeptic UlcerHumansAnti-Inflammatory Agents, Non-SteroidalHelicobacter pyloriJapanEvidence-Based MedicineProton Pump InhibitorsAspirinPractice Guidelines as Topic

Stichwörter der Autor:innen

Helicobacter pyloriAspirinIdiopathic ulcerNonsteroidal anti-inflammatory drugsPeptic ulcer diseaseVonoprazan

Substanzen

Anti-Inflammatory Agents, Non-SteroidalProton Pump InhibitorsAspirin

Autor:innen und Institutionen

  • Guidelines Committee for Creating and Evaluating the ''Evidence-Based Clinical Practice Guidelines for Peptic Ulcer 2026 (4th Edition)," the Japanese Society of Gastroenterology (JSGE), Minato-ku, Tokyo, 105-0004, Japan…
  • Division of Genome-Wide Infectious Microbiology, Research Center for GLOBAL and LOCAL Infectious Disease, Oita University, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan. sugimo@oita-u.ac.jp.
  • Guidelines Committee for Creating and Evaluating the ''Evidence-Based Clinical Practice Guidelines for Peptic Ulcer 2026 (4th Edition)," the Japanese Society of Gastroenterology (JSGE), Minato-ku, Tokyo, 105-0004, Japan.

Zitieren

APA

Sugimoto, M., Kamada, T., Ito, M., Iwamoto, J., Okimoto, T., Ono, S., Kanno, T., Chiba, T., Tokunaga, K., Nomura, S., Murao, T., Watanabe, T., Asaoka, D., Iwata, E., Wang, T., Ono, H., Katsumata, R., Kikuchi, S., Konishi, N., …, & Mochida, S. (2026). Evidence-based clinical practice guidelines for peptic ulcer disease 2026. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02504-3

Vancouver

Sugimoto M, Kamada T, Ito M, Iwamoto J, Okimoto T, Ono S, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2026. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02504-3

BibTeX
@article{Sugimoto2026,
  author = {Sugimoto, Mitsushige and Kamada, Tomoari and Ito, Masanori and Iwamoto, Junichi and Okimoto, Tadayoshi and Ono, Shoko and Kanno, Takeshi and Chiba, Toshimi and Tokunaga, Kengo and Nomura, Sachiyo and Murao, Takahisa and Watanabe, Toshio and Asaoka, Daisuke and Iwata, Eri and Wang, Ting and Ono, Hideki and Katsumata, Ryo and Kikuchi, Satoshi and Konishi, Naoki and Sato, Satoshi and Sunago, Aya and Sekiguchi, Hiromi and Cho, Hourin and Chinda, Daisuke and Dohi, Osamu and Nakata, Akinobu and Higashimori, Akira and Hirashita, Yuka and Misawa, Keigo and Mizukami, Kazuhiro and Miyamori, Daisuke and Mukohyama, Junko and Mori, Hideki and Yoshida, Shuhei and Watanabe, Jun and Satoh, Kiichi and Mizokami, Yuji and Takagi, Atsushi and Takeyama, Yoshifumi and Eguchi, Susumu and Watanabe, Sumio and Isomoto, Hajime and Itoi, Takao and Mochida, Satoshi},
  title = {Evidence-based clinical practice guidelines for peptic ulcer disease 2026},
  journal = {Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s00535-026-02504-3}
}
Kostenlos starten →